OXYGENTA PHARMACEUTICAL Financial Statement Analysis
|
||
|
The Revenues of OXYGENTA PHARMACEUTICAL have increased by 27.93% YoY .
The Earnings Per Share (EPS) of OXYGENTA PHARMACEUTICAL has decreased by Negative YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
OXYGENTA PHARMACEUTICAL Last 5 Annual Financial Results
[BOM: 524636]
| Standalone | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹40 Cr | ₹31 Cr | ₹6,052,481 Cr | ₹52 Cr | ₹14 Cr |
| Expenses | ₹49 Cr | ₹38 Cr | ₹5,904,881 Cr | ₹48 Cr | ₹22 Cr |
| Operating Profit (Excl OI) | ₹-9.70 Cr | ₹-7.12 Cr | ₹147,599 Cr | ₹3.84 Cr | ₹-7.87 Cr |
| Other Income | ₹0.04 Cr | ₹0.02 Cr | ₹455 Cr | ₹0.09 Cr | ₹0.03 Cr |
| Interest | ₹1.59 Cr | ₹1.49 Cr | ₹92,494 Cr | ₹1.78 Cr | ₹1.09 Cr |
| Depreciation | ₹2.66 Cr | ₹2.05 Cr | ₹159,132 Cr | ₹1.20 Cr | ₹1.00 Cr |
| Profit Before Tax | ₹-14 Cr | ₹-11 Cr | ₹-48,936 Cr | ₹3.14 Cr | ₹-5.94 Cr |
| Profit After Tax | ₹-3.48 Cr | ₹-12 Cr | ₹-61,046 Cr | ₹2.93 Cr | ₹-5.79 Cr |
| Earnings Per Share (Rs) | ₹-2.62 | ₹-1.04 | ₹-8.15 | ₹-0.43 | ₹2.87 |
| PAT Margin (%) | -8.86 | -8.78 | -37.34 | -1.01 | 5.63 |
| ROE(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| ROCE(%) | -25.62 | -41.69 | -50.32 | 3.18 | 0.00 |
| Total Debt/Equity(x) | -2.49 | -2.77 | -1.47 | -1.51 | -1.26 |
Key Financials |
||
| Market Cap | : | ₹ 203.5 Cr |
| Revenue (TTM) | : | ₹ 112.1 Cr |
| Net Profit(TTM) | : | ₹ -17.1 Cr |
| EPS (TTM) | : | ₹ -4.6 |
| P/E (TTM) | : | - |
| Industry Peers & Returns | 1W | 1M | 1Y |
| OXYGENTA PHARMACEUTICAL | -1.1% | -7% | -39.6% |
| SUN PHARMACEUTICAL INDUSTRIES | -2.9% | -1.8% | -2.5% |
| DIVIS LABORATORIES | 2.1% | 0.2% | 9.1% |
| CIPLA | 0.7% | -0.8% | 3.4% |
| TORRENT PHARMACEUTICALS | 0.5% | 2.2% | 11.2% |
| DR REDDYS LABORATORIES | -0.1% | 2.5% | 2.5% |
| MANKIND PHARMA | 1.5% | -2.8% | -19.5% |
| ZYDUS LIFESCIENCES | -0.2% | -0.8% | -5.7% |
| LUPIN | 1.7% | 4.7% | 3.5% |
OXYGENTA PHARMACEUTICAL Revenues
[BOM: 524636]
| Y-o-Y | 27.93 % |
| 5 Yr CAGR | 30.39 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹40 Cr | 27.93 | |
| Mar2024 | ₹31 Cr | -100.00 | |
| Mar2023 | ₹6,052,481 Cr | 11,633,245.46 | |
| Mar2022 | ₹52 Cr | 279.32 | |
| Mar2021 | ₹14 Cr | - | |
OXYGENTA PHARMACEUTICAL Operating Profit
[BOM: 524636]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-9.70 Cr | Negative | |
| Mar2024 | ₹-7.12 Cr | Negative | |
| Mar2023 | ₹147,599 Cr | 3,841,628.53 | |
| Mar2022 | ₹3.84 Cr | Positive | |
| Mar2021 | ₹-7.87 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | -24.46% | Negative | |
| Mar2024 | -22.97% | Negative | |
| Mar2023 | 2.44% | -66.94 | |
| Mar2022 | 7.38% | Positive | |
| Mar2021 | -57.36% | - | |
OXYGENTA PHARMACEUTICAL Profit After Tax
[BOM: 524636]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹-3.48 Cr | Negative | |
| Mar2024 | ₹-12 Cr | Negative | |
| Mar2023 | ₹-61,046 Cr | Negative | |
| Mar2022 | ₹2.93 Cr | Positive | |
| Mar2021 | ₹-5.79 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | -8.86 % | Negative | |
| Mar2024 | -8.78 % | Negative | |
| Mar2023 | -37.34 % | Negative | |
| Mar2022 | -1.01 % | Negative | |
| Mar2021 | 5.63 % | - | |
OXYGENTA PHARMACEUTICAL Earnings Per Share (EPS)
[BOM: 524636]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2.62 | Negative | |
| Mar2024 | ₹-1.04 | Negative | |
| Mar2023 | ₹-8.15 | Negative | |
| Mar2022 | ₹-0.43 | Negative | |
| Mar2021 | ₹2.87 | - | |
OXYGENTA PHARMACEUTICAL Return on Capital Employed (ROCE)
[BOM: 524636]
| Y-o-Y | Negative |
| 5 Yr CAGR | 0 |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | -25.62% | Negative | |
| Mar2024 | -41.69% | Negative | |
| Mar2023 | -50.32% | Negative | |
| Mar2022 | 3.18% | 0 | |
| Mar2021 | 0% | - | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Current Share Price | : | ₹55.0 |
| Current MarketCap | : | ₹ 203.5 Cr |
| Updated EOD on | : | Dec 19,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -1.1% |
-7% |
-39.6% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
OXYGENTA PHARMACEUTICAL related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about OXYGENTA PHARMACEUTICAL Financials
How the annual revenues of OXYGENTA PHARMACEUTICAL have changed ?
The Revenues of OXYGENTA PHARMACEUTICAL have increased by 27.93% YoY .
How the Earnings per Share (EPS) of OXYGENTA PHARMACEUTICAL have changed?
The Earnings Per Share (EPS) of OXYGENTA PHARMACEUTICAL has decreased by Negative YoY .
Check out Intrinsic Value of Peers of OXYGENTA PHARMACEUTICAL
Compare Stock Analytics of Peers of OXYGENTA PHARMACEUTICAL
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
